These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 9268990

  • 1. Heterogeneous expression of DNA topoisomerase II alpha isoforms in tumor cell lines.
    Mo YY, Beck WT.
    Oncol Res; 1997; 9(4):193-204. PubMed ID: 9268990
    [Abstract] [Full Text] [Related]

  • 2. Two COOH-terminal truncated cytoplasmic forms of topoisomerase II alpha in a VP-16-selected lung cancer cell line result from partial gene deletion and alternative splicing.
    Yu Q, Mirski SE, Sparks KE, Cole SP.
    Biochemistry; 1997 May 13; 36(19):5868-77. PubMed ID: 9153428
    [Abstract] [Full Text] [Related]

  • 3. DNA topoisomerase II alpha gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells.
    Kubo T, Kohno K, Ohga T, Taniguchi K, Kawanami K, Wada M, Kuwano M.
    Cancer Res; 1995 Sep 01; 55(17):3860-4. PubMed ID: 7641205
    [Abstract] [Full Text] [Related]

  • 4. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG, Slade DL, Parr RL, Feldhoff PW, Sullivan DM, Holguin MH.
    Cancer Res; 1995 Apr 15; 55(8):1707-16. PubMed ID: 7712479
    [Abstract] [Full Text] [Related]

  • 5. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines.
    Chen M, Beck WT.
    Oncol Res; 1995 Apr 15; 7(2):103-11. PubMed ID: 7579726
    [Abstract] [Full Text] [Related]

  • 6. Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells.
    Danks MK, Warmoth MR, Friche E, Granzen B, Bugg BY, Harker WG, Zwelling LA, Futscher BW, Suttle DP, Beck WT.
    Cancer Res; 1993 Mar 15; 53(6):1373-9. PubMed ID: 8383009
    [Abstract] [Full Text] [Related]

  • 7. Cytoplasmic localization of a mutant M(r) 160,000 topoisomerase II alpha is associated with the loss of putative bipartite nuclear localization signals in a drug-resistant human lung cancer cell line.
    Mirski SE, Cole SP.
    Cancer Res; 1995 May 15; 55(10):2129-34. PubMed ID: 7743513
    [Abstract] [Full Text] [Related]

  • 8. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
    Harker WG, Slade DL, Parr RL, Holguin MH.
    Cancer Res; 1995 Nov 01; 55(21):4962-71. PubMed ID: 7585537
    [Abstract] [Full Text] [Related]

  • 9. Quantitation of DNA topoisomerase II alpha messenger ribonucleic acid levels in a small cell lung cancer cell line and two drug resistant sublines using a polymerase chain reaction-aided transcript titration assay.
    Withoff S, Smit EF, Meersma GJ, van den Berg A, Timmer-Bosscha H, Kok K, Postmus PE, Mulder NH, de Vries EG, Buys CH.
    Lab Invest; 1994 Jul 01; 71(1):61-6. PubMed ID: 8041119
    [Abstract] [Full Text] [Related]

  • 10. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors.
    Khélifa T, René B, Le Mée S, Lambert B, Saucier JM, Markovits J, Jacquemin-Sablon H, Jacquemin-Sablon A.
    Cancer Res; 1999 Oct 01; 59(19):4927-36. PubMed ID: 10519406
    [Abstract] [Full Text] [Related]

  • 11. Characterization of a DNA topoisomerase IIalpha gene rearrangement in adriamycin-resistant P388 leukemia: expression of a fusion messenger RNA transcript encoding topoisomerase IIalpha and the retinoic acid receptor alpha locus.
    McPherson JP, Brown GA, Goldenberg GJ.
    Cancer Res; 1993 Dec 15; 53(24):5885-9. PubMed ID: 8261398
    [Abstract] [Full Text] [Related]

  • 12. Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line.
    Feldhoff PW, Mirski SE, Cole SP, Sullivan DM.
    Cancer Res; 1994 Feb 01; 54(3):756-62. PubMed ID: 8306338
    [Abstract] [Full Text] [Related]

  • 13. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME, Holden JA, Brown KA, Harker WG, Perkins SL.
    Mod Pathol; 1997 Mar 01; 10(3):168-75. PubMed ID: 9071722
    [Abstract] [Full Text] [Related]

  • 14. Expression of topoisomerases II alpha and beta in Chinese hamster lung cells resistant to topoisomerase II inhibitors.
    Khélifa T, Casabianca-Pignède MR, René B, Jacquemin-Sablon A.
    Mol Pharmacol; 1994 Aug 01; 46(2):323-8. PubMed ID: 8078494
    [Abstract] [Full Text] [Related]

  • 15. A novel point mutation in the 3' flanking region of the DNA-binding domain of topoisomerase II alpha associated with acquired resistance to topoisomerase II active agents.
    Hashimoto S, Danks MK, Chatterjee S, Beck WT, Berger NA.
    Oncol Res; 1995 Aug 01; 7(1):21-9. PubMed ID: 7549041
    [Abstract] [Full Text] [Related]

  • 16. Characterization of DNA topoisomerase II alpha/beta heterodimers in HeLa cells.
    Gromova I, Biersack H, Jensen S, Nielsen OF, Westergaard O, Andersen AH.
    Biochemistry; 1998 Nov 24; 37(47):16645-52. PubMed ID: 9843432
    [Abstract] [Full Text] [Related]

  • 17. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
    Morgan SE, Cadena RS, Raimondi SC, Beck WT.
    Mol Pharmacol; 2000 Feb 24; 57(2):296-307. PubMed ID: 10648639
    [Abstract] [Full Text] [Related]

  • 18. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
    Vitale L, Frabetti F, Huntsman SA, Canaider S, Casadei R, Lenzi L, Facchin F, Carinci P, Zannotti M, Coppola D, Strippoli P.
    BMC Cancer; 2007 Apr 18; 7():66. PubMed ID: 17442112
    [Abstract] [Full Text] [Related]

  • 19. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
    Sehested M, Wessel I, Jensen LH, Holm B, Oliveri RS, Kenwrick S, Creighton AM, Nitiss JL, Jensen PB.
    Cancer Res; 1998 Apr 01; 58(7):1460-8. PubMed ID: 9537249
    [Abstract] [Full Text] [Related]

  • 20. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
    Chung JG, Yeh KT, Wu SL, Hsu NY, Chen GW, Yeh YW, Ho HC.
    Cancer Res; 2001 Dec 15; 61(24):8873-9. PubMed ID: 11751411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.